中国骨质疏松杂志
中國骨質疏鬆雜誌
중국골질소송잡지
CHINESE JOURNAL OF OSTEOPOROSIS
2015年
1期
44-47
,共4页
田永芝%田发明%张柳%程爱国%梁春雨
田永芝%田髮明%張柳%程愛國%樑春雨
전영지%전발명%장류%정애국%량춘우
骨质疏松症%骨密度%脉冲电磁场%骨重建
骨質疏鬆癥%骨密度%脈遲電磁場%骨重建
골질소송증%골밀도%맥충전자장%골중건
Osteoporosis%Bone mineral density%Pulsed electric-magnetic fields%Bone remodeling
目的:比较脉冲电磁场( pulsed electric?magnetic fields, PEMFs)在原发性骨质疏松症骨重建周期全程干预和半程干预的疗效。方法收集我院2010年10月至2012年1月收治的原发性骨质疏松症患者124例,分成全程组和半程组。全程组62例,采用天津同业TY?PEMFA2型脉冲电磁场治疗仪,采用频率:6-12Hz,强度:9-11mT,共治疗60次,每次40 min,历时5个月。半程组62例,治疗30次,每次40 min,整个疗程历时2个半月。联合口服碳酸钙维生素D3片300 mg 2/d、阿法骨化醇软胶囊1 ug 1/d和阿仑磷酸钠片70 mg 1/w。治疗前后测定全髋、股骨颈和腰椎( L2?L4) BMD值。结果与治疗前相比较,全程组和半程组全髋、股骨颈和腰椎( L2?L4)骨密度均显著升高,两组BMD增长率(%)比较:total hip区全程组BMD为8?31±1?01,半程组5?45±1?17;股骨颈区全程组8?58±1?40,半程组5?44±1?52;腰椎全程组8?02±0?63,半程组4?97±0?49,各部位组间差异均有统计学意义。结论 PEMFs联合药物治疗原发性骨质疏松症,能明显提高患者的骨密度,全程组疗效优于半程组。
目的:比較脈遲電磁場( pulsed electric?magnetic fields, PEMFs)在原髮性骨質疏鬆癥骨重建週期全程榦預和半程榦預的療效。方法收集我院2010年10月至2012年1月收治的原髮性骨質疏鬆癥患者124例,分成全程組和半程組。全程組62例,採用天津同業TY?PEMFA2型脈遲電磁場治療儀,採用頻率:6-12Hz,彊度:9-11mT,共治療60次,每次40 min,歷時5箇月。半程組62例,治療30次,每次40 min,整箇療程歷時2箇半月。聯閤口服碳痠鈣維生素D3片300 mg 2/d、阿法骨化醇軟膠囊1 ug 1/d和阿崙燐痠鈉片70 mg 1/w。治療前後測定全髖、股骨頸和腰椎( L2?L4) BMD值。結果與治療前相比較,全程組和半程組全髖、股骨頸和腰椎( L2?L4)骨密度均顯著升高,兩組BMD增長率(%)比較:total hip區全程組BMD為8?31±1?01,半程組5?45±1?17;股骨頸區全程組8?58±1?40,半程組5?44±1?52;腰椎全程組8?02±0?63,半程組4?97±0?49,各部位組間差異均有統計學意義。結論 PEMFs聯閤藥物治療原髮性骨質疏鬆癥,能明顯提高患者的骨密度,全程組療效優于半程組。
목적:비교맥충전자장( pulsed electric?magnetic fields, PEMFs)재원발성골질소송증골중건주기전정간예화반정간예적료효。방법수집아원2010년10월지2012년1월수치적원발성골질소송증환자124례,분성전정조화반정조。전정조62례,채용천진동업TY?PEMFA2형맥충전자장치료의,채용빈솔:6-12Hz,강도:9-11mT,공치료60차,매차40 min,력시5개월。반정조62례,치료30차,매차40 min,정개료정력시2개반월。연합구복탄산개유생소D3편300 mg 2/d、아법골화순연효낭1 ug 1/d화아륜린산납편70 mg 1/w。치료전후측정전관、고골경화요추( L2?L4) BMD치。결과여치료전상비교,전정조화반정조전관、고골경화요추( L2?L4)골밀도균현저승고,량조BMD증장솔(%)비교:total hip구전정조BMD위8?31±1?01,반정조5?45±1?17;고골경구전정조8?58±1?40,반정조5?44±1?52;요추전정조8?02±0?63,반정조4?97±0?49,각부위조간차이균유통계학의의。결론 PEMFs연합약물치료원발성골질소송증,능명현제고환자적골밀도,전정조료효우우반정조。
Objective To compare the efficacy of different treatment periods with pulse electromagnetic fields ( PEMFs ) on primary osteoporosis. Methods A total of 124 cases of osteoporosis in our hospital from October 2010 to January 2012 were enrolled in this study. They were divided into whole period group and half period group. The patients in whole period group ( 62 cases) received 60 times PEMFs treatment, with 6?12Hz frequency and 9?11mT intensity, using a TY?PEMF A2 ( Tong?Ye Company, Tianjin) . Each treatment lasted for 40 minutes. The total course was 5 months. The patients in the half period treatment group received 30 times treatment. The total course was two and half months. All patients received calcium carbonate and vitamin D 300mg twice a day, alfacalcidol 1 ug once a day, and alendronate sodium pill 70 mg once a week. The bone mineral density of the total hip, femoral neck, and lumbar vertebral ( L2?L4 ) was detected before and after the treatment. Results The BMD of the total hip, femoral neck, and lumbar vertebral L2?L4 in both groups markedly increased after the treatment comparing to that before the treatment. The increasing rates of BMD in whole period group and half period group were 8?31 ± 1?01 and 5?45 ± 1?17 in the total hip, 8?58 ± 1?40 and 5?44 ± 1?52 in the femoral neck, and 8?02 ± 0?63 and 4?97 ± 0?49 in the lumbar vertebrae, respectively. The difference among them was statistically significant. Conclusion PEMFs combined with anti?osteoporosis drugs can increase the BMD of osteoporosis patients. The whole period of PEMFs has better efficacy than half period treatment.